Natural Cycles funding news – Stockholm-based Natural Cycles Secures €50.8 Million in Series C Round Funding

Investments in new product development, commercial acceleration, and healthcare reimbursement automation will be made with the help of a €50.8 million financing that includes participation from Point72 Private Investments and a revolving lending facility from J.P. Morgan.

Dr. Raoul Scherwitzl, co-founder and CEO of Natural Cycles said, “We’ve experienced profitable growth over the last few years as women actively seek more birth control options and we’re excited to welcome the next phase of Natural Cycles journey together with Lauxera Capital Partners and Point72 Private Investments, We look forward to leveraging their expertise to fulfill Natural Cycles’ mission of making hormone-free birth control more accessible and combining technology and science to fill the gaps in underserved areas of women’s health.”

This month, it introduced NC° Postpartum, a cutting-edge feature inside the Natural Cycles app designed to support new mothers as they heal both mentally and physically from childbirth. In order to accompany users throughout their reproductive journey, NC° Postpartum expands on the other three modes already accessible in the Natural Cycles app: NC° Birth Control, NC° Plan Pregnancy, and NC° Follow Pregnancy.

Read also - Iris.ai funding news – Oslo-based Iris.ai Secures €7.64 Million in Funding

Samuel Levy, founding partner of Lauxera Capital Partners said, “Our mission at Lauxera is to partner with ambitious entrepreneurs transforming the future of medicine with unique technology. The visionary Natural Cycles team has built an exceptional company delivering profitable growth supported by unique clinical and regulatory business moats, We are delighted to partner with Elina, Raoul and their team to offer women an alternative to traditional approaches without the side effects and compromises.”

Levy will become a member of Natural Cycles' board of directors as a result of the investment. EQT Ventures, Samsung Ventures, Heartcore Capital, Headline, and Bonnier Ventures are among the existing noteworthy investors of Natural Cycles. Lauxera Capital Partners and Point72 Private Investments join them.

About Natural Cycles

Natural Cycles, founded in 2013 by Drs. Elina Berglund and Raoul Scherwitzl, created the first direct-to-consumer contraceptive app, which is currently in use by over three million people globally. As of right now, it's the only digital birth control method approved by US (FDA), EU (TÜV SÜD), CA (Health Canada), Australia (TGA), HSA (Singapore), and South Korea (MFDS) regulators.